LOVAFARMA

LOVAFARMA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €903,035 and a net result of €411,577. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 69% of 22,238 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).